Product Description
Overall, the global dental core build-up material market (CBU) was valued at $219.9 million in 2022. This is expected to increase over the forecast period at a CAGR of 2.8% to reach $266.6 million.
The full report suite on the global market for dental core build-up (CBU) materials is further segmented into the composite resin, the glass ionomer (GI) and resin-modified GI (RMGI) and the residual segment for other CBU materials used in core procedures. The residual category of other CBU materials combines amalgam, universal cement and silver-reinforced GI. The units sold in the dental CBU material market are defined in millions of grams, while the ASP represents the cost of one gram of a product.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL DENTAL CORE BUILD-UP MATERIAL MARKET INSIGHTS
The composite resin CBU material generated the lion’s share in the global CBU market. These materials offer superior qualities in bond strength to dentin and enamel and a greater range of shades compared with other materials, such as GI/RMGI materials.
Similar to direct restoratives and cements, advancements in material characteristics will drive the overall growth in the CBU market. Bulk-fill advantages can be incorporated in CBU procedures, primarily associated with the use of composite resin materials.
GLOBAL DENTAL CORE BUILD-UP MATERIAL MARKET SHARE INSIGHTS
Within the global market for Dental Core Build-Up Market, there are three key market players – 3M, GC and DMG.
3M’s leading positions in the global CBU material market primarily stemmed from the sales of its Filtek™ and Paradigm™ brands. Filtek™ Supreme Ultra Universal Restorative is preferred by dentists because of its multiple indications in addition to CBU procedures, which simplifies inventory needs. GC was the second-leading competitor in the CBU material market, primarily driven by its recognized leadership in the GI space. GC captured its market share through the sales of its GRADIA® CORE dual-cured radiopaque composite, GC Fuji II® resin-reinforced GI and silver reinforced GI Miracle Mix®. DMG competed in the global CBU material market with its LuxaCore® product line of composite resin materials. LuxaCore® Z-Dual is a premium offering in the composite CBU market.
MARKET SEGMENTATION SUMMARY
- Dental Core Build-Up Material Market – MedCore – The chapter is further broken down by:
- Product Type: Composite Resin, Glass Ionomer/RMGI, and Other;
- Delivery Type: Auto-Mix Syringe, Hand-Mix Powder and Liquid, Pre-Mix;
- Curing Method: Light-Cure, Self-Cure, and Dual-Cure.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regional Coverage | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
